Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y5ZP
|
||||
Former ID |
DNC010086
|
||||
Drug Name |
N-(4-Iodophenyl)-N'-(17-methylmorphinan-3-yl)urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530529] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H28IN3O
|
||||
Canonical SMILES |
CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)NC(=O)NC5=CC=C(C=C5)I
|
||||
InChI |
1S/C24H28IN3O/c1-28-13-12-24-11-3-2-4-20(24)22(28)14-16-5-8-19(15-21(16)24)27-23(29)26-18-9-6-17(25)7-10-18/h5-10,15,20,22H,2-4,11-14H2,1H3,(H2,26,27,29)/t20-,22+,24+/m0/s1
|
||||
InChIKey |
PNKGWKXKIPIROR-BGWNEDDSSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | |
Delta-type opioid receptor | Target Info | Inhibitor | [530529] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.